Open Access DOI:10.23937/2474-3690/1510040
Lactate Dehydrogenase in Hypertensive Disorders in Pregnancy: Severity or Diagnosis Marker?
Fernando Vazquez-Alaniz, Jose Manuel Salas-Pacheco, Ada Agustina Sandoval-Carrillo, Osmel La-llave-Leon, Edna Madai-Mendez Hernandez, Marcelo Barraza-Salas, Eda Guadalupe Ramirez- Valles, Norma Urtiz-Estrada, Mario Lumbreras Marquez, Jose Miguel Montes-Herrera and Cesar Yhamel Sanchez-Bernal
Article Type: Research Article | First Published: June 06, 2019
Lactate dehydrogenase has had an exciting journey as a utility marker in different illnesses, but currently, its clinical utility has been relegated to confirm hemolysis, as a tumor marker, and as a diagnostic biomarker of preeclampsia. The findings of lactate dehydrogenase concentrations taking reference values to healthy persons are not consistent when these are related to hypertensive disorders in pregnancy, mainly to begin symptoms or little severity presentation. The goal in this work was t...
Open Access DOI:10.23937/2474-3690/1510039
It is Possible that there is a Phenotype of the Metabolic Syndrome in Infants
Fernando Aguirre Palacios
Article Type: Editorial | First Published: May 11, 2019
This editorial is dedicated to obesity, overweight, and sedentarism in infants. The original work was published a few months ago in the Journal of Hypertension and Vascular Risk, with the intention of initiating a global campaign to address the pandemic of obesity from an early age, looking for measurement tools that allow monitoring of intervention programs aimed at reducing it. The intention of the present work was to find the simplest proposal, innovative, and novel, to screen, kids with a hi...
Open Access DOI:10.23937/2474-3690/1510038
Nutraceuticals with Blood Pressure Lowering Potential: A Summary of Clinically Relevant Information
Kate Levenberg, David Proctor, Michael Flanagan, Yasina Somani and Faisal Aziz
Article Type: Research Article | First Published: May 11, 2019
Nearly half of patients diagnosed with hypertension are unable to keep their blood pressure under control despite pharmacologic intervention, indicating a need for adjunctive anti-hypertensive therapies. Nutraceuticals may be a promising option for intervention due to their ease of implementation and demonstrated efficacy. The use of nutraceuticals clinically has thus far been limited by a lack of guidelines, likely stemming from a history of poor regulatory standards that allow supplements to g...
Open Access DOI:10.23937/2474-3690/1510037
Role of Nutraceuticals in the Prevention and Treatment of Hypertension and Cardiovascular Diseases
Quiara Lovatti Alves, Samuel Barbosa Camargo and DarIzy Flavia Silva
Article Type: Research Article | First Published: January 21, 2019
Hypertension is the most prevalent risk factor for cardiovascular disease, including coronary heart disease, heart failure, myocardial infarction, stoke, end-stage renal disease and erectile dysfunction. Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and although their etiology were multifactorial, eating habits have been associated with its development. There has been a great deal of interest in studies associating the beneficial effects of food with prevention and tre...
